Skip to main content

Table 4 Anatomical presentation of ML at diagnosis (MNH) by their reviewed histological subtypes (1996 -2006)

From: Tanzanian malignant lymphomas: WHO classification, presentation, ploidy, proliferation and HIV/EBV association

Reviewed histological diagnosis

Anatomical Site [No. (%)]

Reviewed cases with available clinical data

Clinical data unrecorded

Sub-totals

Total reviewed ML

 

Nodal

Extranodal

[No. (%)]

[No. (%)]

[No. (%)]

[No. (%)]

DLBCL

35 (64.8)

7 (25.0)

42

15

57 (50.9)

 

BL

2 (3.7)

15 (53.6)

17

6

23 (20.5)

 

Other BCL*

17 (31.5)

6 (21.4)

23

9

32 (28.6)

 

Total BCL

54 (83.1)

28 (80.0)

82

30

112 (83.6)

112 (83.6)

TCL

11 (16.9)

7 (20.0)

18

4

 

22 (13.7)

TOTAL NHL

65 (65.0)

35 (35.0)

100

34

 

134 (84.8)

HL

10 (66.7)

5 (33.3)

15

9

 

24 (15.2)

TOTAL REVIEWED ML [No. (%)]

75 (65.2)

40 (34.8)

115 (72.8)

43 (27.2)

 

158 (100.0)

  1. *BCL = B-cell lymphomas